Breast Cancer (BCa) and Prostate Cancer (PCa) are the most prevalent tumors in females and males, respectively, being the main causes of cancer morbidity and mortality, worldwide. Currently, there is no available curative treatment for the hormone-resistant tumors, being the development of new therapeutic strategies using innovative anticancer agents imperative. Thus, the main goal of this work was to evaluate the anticancer properties of natural and synthetic compounds through in vitro assays.info:eu-repo/semantics/publishedVersio
